Hasil Pencarian - Niven Mehra

Perbaiki Hasil
  1. 1
    LDH Isotyping for Checkpoint Inhibitor Response Prediction in Patients with Metastatic Melanoma

    LDH Isotyping for Checkpoint Inhibitor Response Prediction in Patients with Metastatic Melanoma oleh Sandra van Wilpe, Sofie H. Tolmeijer, I. Jolanda M. de Vries, Rutger H. T. Koornstra, Niven Mehra

    Diterbitkan 2021-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Bone marrow dosimetry in low volume mHSPC patients receiving Lu-177-PSMA therapy using SPECT/CT

    Bone marrow dosimetry in low volume mHSPC patients receiving Lu-177-PSMA therapy using SPECT/CT oleh Dagmar Grob, Bastiaan M. Privé, Constantijn H. J. Muselaers, Niven Mehra, James Nagarajah, Mark W. Konijnenberg, Steffie M. B. Peters

    Diterbitkan 2024-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Transcriptome Profiling of Circulating Tumor Cells to Predict Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer

    Transcriptome Profiling of Circulating Tumor Cells to Predict Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer oleh Levi Groen, Iris Kloots, David Englert, Kelly Seto, Lana Estafanos, Paul Smith, Gerald W. Verhaegh, Niven Mehra, Jack A. Schalken

    Diterbitkan 2023-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Lactate dehydrogenase: a marker of diminished antitumor immunity

    Lactate dehydrogenase: a marker of diminished antitumor immunity oleh Sandra Van Wilpe, Rutger Koornstra, Martijn Den Brok, Jan Willem De Groot, Christian Blank, Jolanda De Vries, Winald Gerritsen, Niven Mehra

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    172 Cancer immunotherapy response monitoring with whole blood immuno-transcriptomic profiling

    172 Cancer immunotherapy response monitoring with whole blood immuno-transcriptomic profiling oleh Pedro Romero, Niven Mehra, Laura Ciarloni, Noushin Hadadi, Rutger Koornstra, Sandra van Wilpe, Eric Durandau, Sahar Hosseinian Ehrensberger, Sylvain Monnier-Benoit

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discovery

    A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discovery oleh Winald R Gerritsen, Johannes Textor, Niven Mehra, Jeroen H A Creemers, W Joost Lesterhuis, Carl G Figdor, I Jolanda M de Vries

    Diterbitkan 2021-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome

    In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome oleh Jeroen H. A. Creemers, Ankur Ankan, Kit C. B. Roes, Gijs Schröder, Niven Mehra, Carl G. Figdor, I. Jolanda M. de Vries, Johannes Textor

    Diterbitkan 2023-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Immunophenotyping Reveals Longitudinal Changes in Circulating Immune Cells During Radium-223 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer

    Immunophenotyping Reveals Longitudinal Changes in Circulating Immune Cells During Radium-223 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer oleh Jeroen H. A. Creemers, Jeroen H. A. Creemers, Maarten J. van der Doelen, Maarten J. van der Doelen, Sandra van Wilpe, Sandra van Wilpe, Rick Hermsen, Tjitske Duiveman-de Boer, Diederik M. Somford, Marcel J. R. Janssen, J. P. Michiel Sedelaar, Niven Mehra, Niven Mehra, Johannes Textor, Johannes Textor, Harm Westdorp, Harm Westdorp

    Diterbitkan 2021-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    The Androgen Regulated lncRNA <i>NAALADL2-AS2</i> Promotes Tumor Cell Survival in Prostate Cancer

    The Androgen Regulated lncRNA <i>NAALADL2-AS2</i> Promotes Tumor Cell Survival in Prostate Cancer oleh Levi Groen, Viktor Yurevych, Harshitha Ramu, Johnny Chen, Lianne Steenge, Sabrina Boer, Renske Kuiper, Frank P. Smit, Gerald W. Verhaegh, Niven Mehra, Jack A. Schalken

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    High Health-Related Quality of Life During Dendritic Cell Vaccination Therapy in Patients With Castration-Resistant Prostate Cancer

    High Health-Related Quality of Life During Dendritic Cell Vaccination Therapy in Patients With Castration-Resistant Prostate Cancer oleh Harm Westdorp, Harm Westdorp, Jeroen H. A. Creemers, Jeroen H. A. Creemers, Inge M. van Oort, Niven Mehra, Niven Mehra, Simone M. Hins-de Bree, Carl G. Figdor, Carl G. Figdor, J. Alfred Witjes, Gerty Schreibelt, I. Jolanda M. de Vries, I. Jolanda M. de Vries, Winald R. Gerritsen, Winald R. Gerritsen, Petronella B. Ottevanger

    Diterbitkan 2020-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    M1a prostate cancer: Results of a Dutch multidisciplinary consensus meeting

    M1a prostate cancer: Results of a Dutch multidisciplinary consensus meeting oleh Shafak Aluwini, Daniela E. Oprea‐Lager, Hilda deBarros, Niven Mehra, Herman Stoevelaar, Derya Yakar, Henk van derPoel, Dutch M1a Prostate Cancer Working Group

    Diterbitkan 2021-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Utilization of systemic treatment for metastatic bladder cancer in everyday practice: Results of a nation-wide population-based cohort study

    Utilization of systemic treatment for metastatic bladder cancer in everyday practice: Results of a nation-wide population-based cohort study oleh Anke Richters, Niven Mehra, Richard P. Meijer, Joost L. Boormans, Antoine G. van der Heijden, Tineke J. Smilde, Michiel S. van der Heijden, Lambertus A. Kiemeney, Katja K. Aben

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Optimization of the radiation dosimetry protocol in Lutetium-177-PSMA therapy: toward clinical implementation

    Optimization of the radiation dosimetry protocol in Lutetium-177-PSMA therapy: toward clinical implementation oleh Steffie M. B. Peters, Maaike C. T. Mink, Bastiaan M. Privé, Maarten de Bakker, Frank de Lange, Constantijn H. J. Muselaers, Niven Mehra, J. Alfred Witjes, Martin Gotthardt, James Nagarajah, Mark W. Konijnenberg

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Assessing the safety, tolerability and efficacy of PLGA-based immunomodulatory nanoparticles in patients with advanced NY-ESO-1-positive cancers: a first-in-human phase I open-label dose-escalation study protocol

    Assessing the safety, tolerability and efficacy of PLGA-based immunomodulatory nanoparticles in patients with advanced NY-ESO-1-positive cancers: a first-in-human phase I open-labe... oleh Mark R Middleton, Winald R Gerritsen, Ian Walters, Licia Rivoltini, Niven Mehra, Jeroen H A Creemers, Carl G Figdor, I Jolanda M de Vries, Uzi Gileadi, Inka Pawlitzky, Konstantina Grosios, Petronella B Ottevanger

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Treatment Patterns and Use of Immune Checkpoint Inhibitors Among Patients with Metastatic Bladder Cancer in a Dutch Nationwide Cohort

    Treatment Patterns and Use of Immune Checkpoint Inhibitors Among Patients with Metastatic Bladder Cancer in a Dutch Nationwide Cohort oleh Anke Richters, Debbie G.J. Robbrecht, Richard P. Meijer, Antoine G. van der Heijden, Lambertus A.L.M. Kiemeney, Joan van den Bosch, Britt B.M. Suelmann, Berna C. Özdemir, Niven Mehra, Katja K.H. Aben

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    ModraDoc006, an oral docetaxel formulation in combination with ritonavir (ModraDoc006/r), in metastatic castration‐resistant prostate cancer patients: A phase Ib study

    ModraDoc006, an oral docetaxel formulation in combination with ritonavir (ModraDoc006/r), in metastatic castration‐resistant prostate cancer patients: A phase Ib study oleh Marit A. C. Vermunt, Debbie G. J. Robbrecht, Lot A. Devriese, Julie M. Janssen, Bas Thijssen, Marianne Keessen, Maarten vanEijk, Rob Kessels, Ferry A. L. M. Eskens, Jos H. Beijnen, Niven Mehra, Andries M. Bergman

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Liquid biopsy reveals KLK3 mRNA as a prognostic marker for progression free survival in patients with metastatic castration‐resistant prostate cancer undergoing first‐line abiraterone acetate and prednisone treatment

    Liquid biopsy reveals KLK3 mRNA as a prognostic marker for progression free survival in patients with metastatic castration‐resistant prostate cancer undergoing first‐line abirater... oleh Emmy Boerrigter, Guillemette E. Benoist, Inge M. vanOort, Gerald W. Verhaegh, Onno vanHooij, Levi Groen, Frank Smit, Irma M. Oving, Pieter deMol, Tineke J. Smilde, Diederik M. Somford, Niven Mehra, Jack A. Schalken, Nielka P. vanErp

    Diterbitkan 2021-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Spatial and Temporal Heterogeneity of Tumor-Infiltrating Lymphocytes in Advanced Urothelial Cancer

    Spatial and Temporal Heterogeneity of Tumor-Infiltrating Lymphocytes in Advanced Urothelial Cancer oleh Sandra van Wilpe, Mark A. J. Gorris, Mark A. J. Gorris, Lieke L. van der Woude, Lieke L. van der Woude, Shabaz Sultan, Rutger H. T. Koornstra, Antoine G. van der Heijden, Winald R. Gerritsen, Michiel Simons, I. Jolanda M. de Vries, Niven Mehra

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    TripleAiM1: a nationwide registry of de novo metastatic hormone-sensitive prostate cancer with prospective quality-of-life assessment

    TripleAiM1: a nationwide registry of de novo metastatic hormone-sensitive prostate cancer with prospective quality-of-life assessment oleh Sjoerd Klaver, André Vis, Gerard Vreugdenhil, Niven Mehra, Tessa van Elst, Jean-Paul van Basten, Pieter van den Berg, Roderick van den Bergh, Sjaak Bloem, Joyce van Dodewaard-de Jong, Mathijs Hendriks, Zarina Lalmahomed, Daphne Luijendijk, Addy van de Luijtgaarden, Luc Roelofs, Eric Vrijhof, Bart Wijsman, Haiko Bloemendal, Peter Mulders

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Homologous recombination repair deficient prostate cancer represents an immunologically distinct subtype

    Homologous recombination repair deficient prostate cancer represents an immunologically distinct subtype oleh Sandra van Wilpe, Donjetë Simnica, Peter Slootbeek, Thomas van Ee, Samhita Pamidimarri Naga, Mark A. J. Gorris, Lieke L. van der Woude, Shabaz Sultan, Rutger H. T. Koornstra, Inge M. van Oort, Winald R. Gerritsen, Leonie I. Kroeze, Michiel Simons, Geert J. L. H. van Leenders, Mascha Binder, I. Jolanda M. de Vries, Niven Mehra

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: